No menu items!

U.S. pledges support for Ecuador’s anti-drug initiatives

The United States has committed additional funding to its drug-control partnership with Ecuador, aiming to amplify the nation’s research and preventive actions against drug trafficking and organized crime.

This move also targets the enhancement and restructuring of the judicial sector.

The recent commitment was unveiled by Ecuador’s Ministry of Foreign Affairs and Human Mobility after endorsing “Amendment 19” to a cooperation agreement formed in 2002.

This amendment’s main goal is for the U.S. to support Ecuador in enhancing its operational effectiveness against high-profile crimes, primarily those linked to drug trafficking.

Photo Internet reproduction. (Photo Internet reproduction)
Photo Internet reproduction. (Photo Internet reproduction)

Ecuador’s Foreign Minister, Gustavo Manrique, mentioned that this revision will usher in more resources, primarily benefitting several national institutions, such as the Armed Forces, National Police, and the Judiciary.

These additional resources from the U.S. will channel into two pivotal projects: “public safety and order” and “judicial sector capacity building and reforms.”

From 2002 to 2022, through the International Narcotics and Law Enforcement Affairs Office, the U.S. has steadily provided Ecuador with resources to reinforce its battle against drug-related crimes.

Positioned between cocaine-producing giants Colombia and Peru, Ecuador witnesses significant drug-related violence, climaxing in 2022 with its highest ever homicide rate of 25.32 per 100,000 inhabitants.

Organized crime factions are in constant contention for control over cocaine, majorly sourced from Colombia, making its way to global markets, predominantly the U.S. and Europe.

As of recent records, Ecuador confiscated 117 tons of drugs, positioning itself as the third-highest globally in terms of seizures, trailing only Colombia and the U.S.

Check out our other content

×
You have free article(s) remaining. Subscribe for unlimited access.